文献速递其他结缔组织病

系统性硬化症相关间质性肺病中呼吸困难加重的预后意义

The prognostic importance of worsening dyspnoea in systemic sclerosis related interstitial lung disease.
PubMed 文献 · Semin Arthritis Rheum · 2025-09-05

基于澳大利亚硬皮病队列研究纳入2198例系统性硬化症患者,中位随访5.8年,17.7%(n=389)出现新发间质性肺病,其中38.3%(n=149)经历间质性肺病进展。在进展性间质性肺病患者中,报告近一个月内呼吸困难加重者死亡率显著更高,且不受肺功能指标下降的影响。

要点

  • 新发间质性肺病占系统性硬化症患者的17.7%,中位随访5.8年。
  • 进展性间质性肺病占新发间质性肺病患者的38.3%。
  • 进展性间质性肺病中,近一月呼吸困难加重与死亡率显著相关,不受肺功能变化影响。

核心结论

  • 新发间质性肺病患者中38.8%在随访期间经历间质性肺病进展。
  • 患者报告近一月内呼吸困难加重与死亡率强烈相关,其程度相当于按ATS、INBUILD及肺功能定义判定的进展性间质性肺病,且不受肺功能变化影响。
  • 本研究强调了患者报告症状在系统性硬化症相关间质性肺病评估中的预后重要性。

研究设计与样本

  • 研究从澳大利亚硬皮病队列研究中招募系统性硬化症患者。
  • 间质性肺病定义为高分辨率计算机断层扫描(HRCT)上见特征性纤维化改变,基于临床怀疑而进行扫描。
  • 采用加速失效时间生存分析评估系统性硬化症相关间质性肺病患者的生存决定因素,特别是间质性肺病进展(按ATS、INBUILD及肺功能定义的进展性肺纤维化)及呼吸困难加重的预后影响。

主要发现

  • 在2198例系统性硬化症患者中,17.7%(n=389)在中位(IQR)随访5.8(2.8-9.9)年期间出现新发间质性肺病。
  • 新发间质性肺病队列中三分之一(38.3%,n=149)经历进展性间质性肺病。
  • 在经历进展性间质性肺病的患者中,报告近一月内呼吸困难加重者死亡率显著更高,不受肺功能指标下降的影响。

关键数值与推荐

  • 间质性肺病定义:HRCT见特征性纤维化改变,基于临床怀疑而进行扫描。
  • 进展性间质性肺病按ATS、INBUILD及肺功能定义判定。
  • 呼吸困难加重定义为患者报告近一月内呼吸困难加重。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To determine the prognostic importance of worsening dyspnoea in systemic sclerosis (SSc) related interstitial lung disease (ILD). METHODS: SSc patients were recruited from the Australian Scleroderma Cohort Study. ILD was defined as present if characteristic fibrotic changes on high-resolution computer tomography (HRCT) scan lung were seen, performed based on clinical suspicion. Determinants of survival in SSc-ILD were analysed, specifically the prognostic impact of ILD progression, defined according to the ATS, INBUILD and spirometric definitions of progressive pulmonary fibrosis, and the presence of worsening dyspnoea using accelerated failure time survival analysis. RESULTS: In our cohort of 2198 SSc patients, 17.7% (n = 389) developed incident ILD over a median (IQR) follow-up period of 5.8 (2.8-9.9) years. A third of our incident ILD cohort (38.3%, n = 149) experienced progressive ILD. In those who experienced progressive ILD, mortality was significantly higher in those who reported recent worsening dyspnoea in the prior month irrespective of a decline in spirometric parameters. CONCLUSION: 38.8% of those with incident ILD experienced ILD progression over follow-up. Patient-reported worsening dyspnoea in the month prior, irrespective of changes in spirometry, was strongly associated with mortality, with a magnitude equivalent to that of the presence of progressive ILD as defined by the ATS, INBUILD and spirometric definitions of progressive ILD. This study has highlighted the prognostic importance of patient-reported symptoms in the evaluation of SSc-ILD.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Morrisroe K, Hansen D, Stevens W, et al. The prognostic importance of worsening dyspnoea in systemic sclerosis related interstitial lung disease. Semin Arthritis Rheum. 2025. PMID: 40974697. doi:10.1016/j.semarthrit.2025.152826

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。